Ultra-long-term toxicity of prostate brachytherapy
The true long-term toxicity associated with most radiation treatments is unknown. Prostate cancer patients survive decades after prostate cancer brachytherapy, with unclear long-term toxicity profiles. We therefore evaluated prostate cancer patients who had received I-125 brachytherapy treatment (14,400 cGy) 14–24 years prior and assessed their long-term quality of life based on urinary, bowel, and sexual function.
Source: Brachytherapy - Category: Cancer & Oncology Authors: Elizabeth Thompson, William Barrett Source Type: research